Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.

Allam, Magdy Mohamed; El-Zawawy, Hanaa Tarek; Kader Okda, Amr Abdel; Ali Alshaikh, Ayoub; Ghazy, Ramy Mohamed

Allam, Magdy Mohamed; El-Zawawy, Hanaa Tarek; Kader Okda, Amr Abdel; Ali Alshaikh, Ayoub; Ghazy, Ramy Mohamed.

Afiliação

Allam MM; Endocrinology Unit , Department of Internal Medicine, Alexandria University Student Hospital, Alexandria University, Alexandria, Egypt.
El-Zawawy HT; Endocrinology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Kader Okda AA; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Ali Alshaikh A; Family & Community Medicine Department, King Khalid University, Abha, Saudi Arabia.
Ghazy RM; Tropical Health Department, High Institute of Public Health Alexandria University, Alexandria, Egypt.

Front Endocrinol (Lausanne) ; 14: 1168936, 2023.

Article em En | MEDLINE | ID: mdl-37409226

Assuntos

Azatioprina; Doença de Graves; Humanos; Azatioprina/uso terapêutico; Propranolol/uso terapêutico; Antitireóideos/uso terapêutico; Doença de Graves/tratamento farmacológico; Tireotropina; Carbimazol; Anticorpos/análise; Recidiva

Palavras-chave

Graves' disease; antithyroid drugs; azathioprine; relapse rate; remission rate

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_transmissiveis Assunto principal: Azatioprina / Doença de Graves Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google